Support PenkeNektar Therapeutics - Trending symbols
Latest News of Nektar Therapeutics
| Date | Title | Read |
|---|---|---|
| 2025-11-07 22:26 | Nektar outlines $1B market opportunity for REZPEG in alopecia areata as Phase III plans advance | Read |
| 2025-11-07 16:11 | Nektar Therapeutics Q3 Loss Narrower Than Expected, Revenues Rise Y/Y | Read |
| 2025-11-06 22:29 | Nektar Therapeutics Non-GAAP EPS of $1.85 beats by $4.64, revenue of $11.79M beats by $1.59M | Read |
| 2025-10-19 12:22 | IRON Gets Stronger, MNMD Sends A Soothing Signal To Investors, Will Christmas Come Early For NKTR? | Read |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Stockholder Equity | 79,688 | -30,804 | 48,884 | 11,853 | 60,737 | -46,999 | 13,738 | -37,949 | -24,211 | |
| Net Invested Capital | 79,688 | -30,804 | 48,884 | 11,853 | 60,737 | -46,999 | 13,738 | -37,949 | -24,211 | |
| Net Income from Continuing Operations | -42,079 | 5,277 | -36,802 | -15,561 | -52,363 | 15,306 | -37,057 | 44,318 | 7,261 | |
| EBIT | -35,241 | 3,935 | -31,306 | -14,603 | -45,909 | 10,571 | -35,338 | 52,493 | 17,155 | |
| EBITDA | -33,589 | 3,890 | -29,699 | -14,751 | -44,450 | 10,105 | -34,345 | 51,832 | 17,487 | |
| Operating Income | -30,660 | -3,792 | -34,452 | -2,033 | -36,485 | 2,140 | -34,345 | 48,693 | 14,348 | |
| Income before Tax | -42,108 | 5,271 | -36,837 | -15,480 | -52,317 | 15,269 | -37,048 | 44,050 | 7,002 | |
| Net Income | -42,079 | 5,277 | -36,802 | -15,561 | -52,363 | 15,306 | -37,057 | 44,318 | 7,261 | |
| Total Other Income Expense Net | -8,597 | 6,212 | -2,385 | -13,447 | -15,832 | 13,129 | -2,703 | 41,598 | 38,895 | |
| Tax Provision | -47 | -14 | -61 | 32 | -29 | -6 | -35 | 81 | 46 | |
| Income Tax Expense | -47 | -14 | -61 | 32 | -29 | -6 | -35 | 81 | 46 | |
| Accumulated Other Comprehensive Income | -6,907 | 1,226 | -5,681 | -769 | -6,450 | 98 | -6,352 | 6,432 | 80 | |
| Net non Operating Income Other | -187 | -1,681 | -1,868 | -1,329 | -3,197 | -21,415 | -24,612 | 58,434 | 33,822 |
Comments
How you think about this?